Arkolith/Insider Trading/TCRX/Form 4

Lynx1 Capital Management LP

10% OwnerTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Dec 23, 2025
Net Buying
Open-Market Buys
$146K
Open-Market Sells
$0
Net Open-Market Flow
$146K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2025Buy(P)6K$0.90$6K8.0M
Dec 22, 2025Buy(P)76K$0.90$68K8.0M
Dec 19, 2025Buy(P)80K$0.90$72K7.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-005396) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML